Involving 5 listed companies! The 'C-class' sanitary napkin is suspected of being unhygienic. The product inspection report reveals the truth.
① The topic of "Category C sanitary napkins" continues to ferment, with controversy focusing on pH value and formaldehyde content; ② Reporters obtained inspection reports from eight sanitary napkin brands, most of which can reach Category A; ③ Category A and C are textile standards, but indicators like pH value are also adopted in sanitary napkins; ④ It is precisely based on the pH value and formaldehyde indicators that netizens question whether the sanitary napkin standards only reach Category C.
Unveil! With huge trading volume, which A-shares are institutions chasing after?
The heat of A shares is still continuing!
Rise of Domestic Sanitary Napkins Accelerated by E-commerce, with over 40% of Chongqing Baiya Sanitary Products' Revenue Coming from Online Sales | Interpretations
①Chongqing Baiya Sanitary Products accelerated its performance growth in the first half of the year. The core driving force comes from online, accounting for more than 40%. ②Marketing expenses have increased significantly, becoming a common hidden worry in the consumer goods industry.
“Clearance” dividends? Marketing-driven performance problem unsolved Baiya Co., Ltd. plans to split 99% of the year's net profit|Annual Report Interpretation
① Net profit returned to growth in 2023, and Baiya shares vigorously paid dividends; ② The company plans to distribute a cash dividend of 236 million yuan, which will almost completely split the net profit for the whole year; ③ Despite the increase in performance, the company's profitability index did not rise but fell due to the surge in marketing costs.
Net profit fell nearly 40% in the first three quarters, can Zhongshun Jierou's profit return to positive growth for the full year of 2023? |Interpretation of financial reports
① Zhongshun Jierou did not increase revenue and profit in the first three quarters of this year, with net profit falling nearly 40% year on year; ② According to estimates, if the company wants to achieve positive profit growth throughout 2023, it will need to complete a net profit of at least 185 million yuan in the Q4 quarter; there is still a gap of 3.177 billion yuan from achieving the revenue target of 10 billion yuan in 2023. ③ The company said it will catch up with goals such as comprehensively fighting the online Double 11 war and starting the Spring Festival takeover campaign ahead of schedule.
Relying on asset disposal to support a high performance base, steady medical care deducted non-net profit fell by more than 40% in the first three quarters|Interpretation of financial reports
① Under the influence of the high base brought about by infection protection products in the same period last year, Robust Medical's revenue for the first three quarters of this year fell by more than 20% year on year, but net profit increased due to increased asset disposal income; ② Regarding the decline in non-net profit after deducting Q3, the company said that it was mainly due to a decrease in sales revenue from infection protection products in the medical sector and a decline in gross margin due to changes in the medical product structure.